BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,371,472 | -27.0% | 36,340 | -11.9% | 0.04% | -14.6% |
| Q2 2023 | $1,879,669 | +11.2% | 41,257 | -1.0% | 0.05% | +6.7% |
| Q1 2023 | $1,690,703 | -19.8% | 41,684 | +0.8% | 0.04% | -23.7% |
| Q4 2022 | $2,108,527 | -4.5% | 41,368 | +0.9% | 0.06% | -10.6% |
| Q3 2022 | $2,208,000 | -15.5% | 40,997 | +0.7% | 0.07% | +4.8% |
| Q2 2022 | $2,614,000 | -17.3% | 40,697 | -0.1% | 0.06% | +1.6% |
| Q1 2022 | $3,159,000 | -10.9% | 40,745 | -1.3% | 0.06% | -4.6% |
| Q4 2021 | $3,545,000 | +5.8% | 41,292 | -0.9% | 0.06% | -5.8% |
| Q3 2021 | $3,350,000 | -1.9% | 41,649 | -1.8% | 0.07% | 0.0% |
| Q2 2021 | $3,414,000 | -5.4% | 42,408 | -0.9% | 0.07% | -11.5% |
| Q1 2021 | $3,608,000 | +0.4% | 42,785 | -4.5% | 0.08% | -3.7% |
| Q4 2020 | $3,593,000 | -3.8% | 44,784 | -3.5% | 0.08% | -11.0% |
| Q3 2020 | $3,733,000 | -8.1% | 46,413 | -1.6% | 0.09% | -12.5% |
| Q2 2020 | $4,063,000 | -0.3% | 47,187 | -6.0% | 0.10% | -9.6% |
| Q1 2020 | $4,075,000 | -4.4% | 50,197 | -1.5% | 0.12% | +22.3% |
| Q4 2019 | $4,263,000 | -7.6% | 50,982 | -3.4% | 0.09% | -11.3% |
| Q3 2019 | $4,615,000 | +14.5% | 52,758 | +7.2% | 0.11% | +14.0% |
| Q2 2019 | $4,031,000 | +0.8% | 49,217 | +0.0% | 0.09% | -2.1% |
| Q1 2019 | $4,000,000 | +20.2% | 49,199 | -2.7% | 0.10% | +6.7% |
| Q4 2018 | $3,327,000 | -14.7% | 50,545 | -0.1% | 0.09% | -4.3% |
| Q3 2018 | $3,899,000 | +5.3% | 50,582 | +0.9% | 0.09% | +1.1% |
| Q2 2018 | $3,703,000 | +13.0% | 50,150 | -0.4% | 0.09% | +9.5% |
| Q1 2018 | $3,276,000 | -0.5% | 50,363 | -1.2% | 0.08% | +3.7% |
| Q4 2017 | $3,294,000 | +4.0% | 50,958 | +1.0% | 0.08% | -1.2% |
| Q3 2017 | $3,166,000 | +6.4% | 50,457 | +2.7% | 0.08% | +5.1% |
| Q2 2017 | $2,976,000 | +17.5% | 49,151 | +0.7% | 0.08% | +14.7% |
| Q1 2017 | $2,532,000 | +17.0% | 48,827 | -0.0% | 0.07% | +17.2% |
| Q4 2016 | $2,165,000 | -5.5% | 48,838 | +1.5% | 0.06% | -6.5% |
| Q3 2016 | $2,290,000 | -5.6% | 48,101 | -10.4% | 0.06% | -8.8% |
| Q2 2016 | $2,427,000 | +12.1% | 53,678 | +1.8% | 0.07% | +9.7% |
| Q1 2016 | $2,165,000 | +8.6% | 52,703 | +0.8% | 0.06% | +5.1% |
| Q4 2015 | $1,994,000 | +19.4% | 52,263 | +2.8% | 0.06% | +7.3% |
| Q3 2015 | $1,670,000 | -53.5% | 50,834 | -1.1% | 0.06% | -50.9% |
| Q2 2015 | $3,595,000 | +3.7% | 51,415 | +1.6% | 0.11% | +10.9% |
| Q1 2015 | $3,468,000 | -3.7% | 50,627 | +3.1% | 0.10% | -9.0% |
| Q4 2014 | $3,600,000 | +4.3% | 49,120 | +2.2% | 0.11% | -5.1% |
| Q3 2014 | $3,451,000 | -1.3% | 48,082 | -0.6% | 0.12% | -0.8% |
| Q2 2014 | $3,498,000 | -2.2% | 48,380 | -0.5% | 0.12% | -9.2% |
| Q1 2014 | $3,578,000 | +6.0% | 48,623 | +0.2% | 0.13% | +1.6% |
| Q4 2013 | $3,375,000 | +6.8% | 48,528 | +0.8% | 0.13% | +0.8% |
| Q3 2013 | $3,161,000 | -3.7% | 48,120 | +1.6% | 0.13% | -4.5% |
| Q2 2013 | $3,281,000 | -1.9% | 47,368 | +2.8% | 0.13% | -2.9% |
| Q1 2013 | $3,346,000 | +8.0% | 46,064 | -0.8% | 0.14% | -0.7% |
| Q4 2012 | $3,097,000 | +8.4% | 46,454 | -2.0% | 0.14% | +7.8% |
| Q3 2012 | $2,856,000 | +12.8% | 47,388 | -0.5% | 0.13% | +7.6% |
| Q2 2012 | $2,532,000 | -13.4% | 47,632 | -2.6% | 0.12% | -9.8% |
| Q1 2012 | $2,923,000 | +21.4% | 48,899 | +0.5% | 0.13% | +7.3% |
| Q4 2011 | $2,407,000 | -12.9% | 48,644 | -1.2% | 0.12% | -22.6% |
| Q3 2011 | $2,765,000 | – | 49,247 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |